Tower Research Capital (TRC)’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89.6K | Sell |
|
|||||
|
2025
Q2 | $47.9K | Buy |
|
|||||
|
2025
Q1 | $24.1K | Sell |
|
|||||
|
2024
Q4 | $174K | Buy |
|
|||||
|
2024
Q3 | $31.2K | Sell |
|
|||||
|
2024
Q2 | $60.7K | Buy |
|
|||||
|
2024
Q1 | $29.2K | Sell |
|
|||||
|
2023
Q4 | $181K | Buy |
|
|||||
|
2023
Q3 | $72.7K | Sell |
|
|||||
|
2023
Q2 | $92K | Buy |
|
|||||
|
2023
Q1 | $54K | Sell |
|
|||||
|
2022
Q4 | $70K | Sell |
|
|||||
|
2022
Q3 | $86K | Sell |
|
|||||
|
2022
Q2 | $64K | Buy |
|
|||||
|
2022
Q1 | $10K | Buy |
|